Another step towards getting a lateral flow diagnostic test for long covid.
Revive held a meeting online with the FDA who granted them approval to move to the next stage by suggesting they follow a set protocol and present a clinical study to go along with the De Novo submission.
Revive have agreed to the conditions and seem confident enough to already be setting up production contracts with manufacturers.
TORONTO, June 10, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures...
uk.finance.yahoo.com
I think this will be a significant step forward in evidentionally showing that long covid persists, and with creating treatments.
But I think the biggest significance is for peace of mind for the people not being believed by certain doctors, friends, and in some cases family.
There seems to be a noticeable amount of doctors, based on comments they have made, that think having low blood oxygen levels is psychological.